• Profile
Close

Retinal fluid volatility associated with interval tolerance and visual outcomes in diabetic macular edema in the VISTA phase III trial

American Journal of Ophthalmology Dec 02, 2020

Ehlers JP, Uchida A, Sevgi DD, et al. - In this post hoc sub-analysis of phase III, VISTA-DME study, researchers sought to characterize longitudinal retinal fluid dynamics on spectral domain OCT and to identify imaging biomarkers that anticipate the worsening of DME with interval extension during anti-vascular endothelial growth factor therapy. Eyes got either intravitreal aflibercept injection 2 mg every 4 weeks (2q4) or every 8 weeks after 5 initial monthly injections (2q8), and eyes imaged with the Cirrus HD-OCT system were involved. Fifty-five eyes were involved in the 2q4 group, and 58 eyes were involved in the 2q8 group. Early fluid dynamics is related to intolerance of interval extension as calculated by early retinal fluid index (RFI) volatility and cumulative RFI instability with aggregate increased RFI.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay